Stem Cell Transplantation for Frailty.
作者信息
Le Couteur David G, Anderson Rozalyn M, Newman Anne B, de Cabo Rafael
机构信息
Centre for Education and Research on Aging, Charles Perkins Centre and ANZAC Research Institute, University of Sydney and Concord Hospital, New South Wales, Australia.
Department of Medicine, University of Wisconsin-Madison GRECC, William S Middleton Memorial Veterans Hospital.
出版信息
J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1503-1504. doi: 10.1093/gerona/glx158.
Abstract
摘要
相似文献
1
Stem Cell Transplantation for Frailty.用于衰弱症的干细胞移植
J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1503-1504. doi: 10.1093/gerona/glx158.
2
Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics.间充质干细胞治疗与衰老衰弱：从机制到治疗学。
Theranostics. 2021 Mar 31;11(12):5675-5685. doi: 10.7150/thno.46436. eCollection 2021.
3
Meeting report: Adult Mesenchymal Stem Cells in Regenerative Medicine conference, August 2007.会议报告：2007年8月再生医学中的成人间充质干细胞会议
Stem Cells. 2007 Nov;25(11):2973-4. doi: 10.1634/stemcells.2007-0769. Epub 2007 Sep 20.
4
Practice of postponing human aging.延缓人类衰老的实践。
Rejuvenation Res. 2010 Apr-Jun;13(2-3):356-8. doi: 10.1089/rej.2009.0952.
5
Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy?间充质干细胞作为治疗心脏病的生物药物：基于细胞的心脏治疗进展如何？
Circ Res. 2015 Jul 17;117(3):229-33. doi: 10.1161/CIRCRESAHA.117.306306.
6
Use of dental stem cells in regenerative dentistry: a possible alternative.牙干细胞在再生牙科中的应用：一种可能的替代方法。
Transl Res. 2011 Dec;158(6):385-6. doi: 10.1016/j.trsl.2011.07.008. Epub 2011 Aug 24.
7
Frailty and Rejuvenation with Stem Cells: Therapeutic Opportunities and Clinical Challenges.衰弱与干细胞的年轻化：治疗机遇与临床挑战。
Rejuvenation Res. 2019 Dec;22(6):484-497. doi: 10.1089/rej.2017.2048. Epub 2019 Mar 21.
8
Ageing: Develop models of frailty.衰老：建立衰弱模型。
Nature. 2014 Aug 21;512(7514):253. doi: 10.1038/512253d.
9
The rejuvenation of aged stem cells for cardiac repair.衰老心脏干细胞的再生修复。
Can J Cardiol. 2014 Nov;30(11):1299-306. doi: 10.1016/j.cjca.2014.03.021. Epub 2014 Mar 20.
10
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.通过静脉输注异体人骨髓间充质干细胞（hMSC）治疗衰老虚弱患者的原理与设计（CRATUS）研究：一项I/II期随机、双盲、安慰剂对照试验，旨在评估异体人骨髓间充质干细胞输注对衰老虚弱患者的安全性和潜在疗效。
Oncotarget. 2016 Mar 15;7(11):11899-912. doi: 10.18632/oncotarget.7727.
引用本文的文献
1
Current Clinical Implications of Frailty and Sarcopenia in Vascular Surgery: A Comprehensive Review of the Literature and Consideration of Perioperative Management.血管外科中衰弱和肌肉减少症的当前临床意义：文献综述与围手术期管理考量
Ann Vasc Dis. 2022 Sep 25;15(3):165-174. doi: 10.3400/avd.ra.22-00035.
2
Does diet influence aging? Evidence from animal studies.饮食会影响衰老吗？来自动物研究的证据。
J Intern Med. 2024 Apr;295(4):400-415. doi: 10.1111/joim.13530. Epub 2022 Jun 24.
3
Mesenchymal Stem Cell Transplantation for the Treatment of Age-Related Musculoskeletal Frailty.间质干细胞移植治疗与年龄相关的肌肉骨骼虚弱。
Int J Mol Sci. 2021 Sep 29;22(19):10542. doi: 10.3390/ijms221910542.
4
Increasing cytosolic Ca levels restore cell proliferation and stem cell potency in aged MSCs.提高细胞浆内 Ca 水平可恢复衰老间充质干细胞的细胞增殖和干细胞潜能。
Stem Cell Res. 2021 Oct;56:102560. doi: 10.1016/j.scr.2021.102560. Epub 2021 Oct 3.
5
Inflammation, a common mechanism in frailty and COVID-19, and stem cells as a therapeutic approach.炎症是衰弱和 COVID-19 的共同机制，而干细胞则是一种治疗方法。
Stem Cells Transl Med. 2021 Nov;10(11):1482-1490. doi: 10.1002/sctm.21-0074. Epub 2021 Aug 3.
6
Senescence-Associated Secretory Phenotype Suppression Mediated by Small-Sized Mesenchymal Stem Cells Delays Cellular Senescence through TLR2 and TLR5 Signaling.小尺寸间充质干细胞通过 TLR2 和 TLR5 信号抑制衰老相关分泌表型可延缓细胞衰老。
Cells. 2021 Jan 3;10(1):63. doi: 10.3390/cells10010063.
7
Frailty and Rejuvenation with Stem Cells: Therapeutic Opportunities and Clinical Challenges.衰弱与干细胞的年轻化：治疗机遇与临床挑战。
Rejuvenation Res. 2019 Dec;22(6):484-497. doi: 10.1089/rej.2017.2048. Epub 2019 Mar 21.
8
Journal of Gerontology: Biological Sciences. A Long Tradition in Advancing Aging Biology and Translational Gerontology.《老年学杂志：生物科学》。在推进衰老生物学和转化老年医学方面有着悠久传统。
J Gerontol A Biol Sci Med Sci. 2018 Mar 2;73(3):271-272. doi: 10.1093/gerona/gly004.
本文引用的文献
1
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.异体间充质干细胞改善衰老虚弱：一项II期随机、双盲、安慰剂对照临床试验。
J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1513-1522. doi: 10.1093/gerona/glx137.
2
Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation.血管衰老：血管年轻化的分子机制和潜在治疗方法。
Ageing Res Rev. 2017 Aug;37:94-116. doi: 10.1016/j.arr.2017.05.006. Epub 2017 Jun 1.
3
A Comparison of Two Mouse Frailty Assessment Tools.两种小鼠衰弱评估工具的比较
J Gerontol A Biol Sci Med Sci. 2017 Jul 1;72(7):904-909. doi: 10.1093/gerona/glx009.
4
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.异基因人骨髓间充质干细胞输注治疗衰老虚弱症
J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1505-1512. doi: 10.1093/gerona/glx056.
5
Rejuvenating Strategies for Stem Cell-Based Therapies in Aging.衰老过程中基于干细胞疗法的年轻化策略
Cell Stem Cell. 2017 Feb 2;20(2):161-175. doi: 10.1016/j.stem.2017.01.008.
6
In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.通过部分重编程在体内改善与年龄相关的特征
Cell. 2016 Dec 15;167(7):1719-1733.e12. doi: 10.1016/j.cell.2016.11.052.
7
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.通过静脉输注异体人骨髓间充质干细胞（hMSC）治疗衰老虚弱患者的原理与设计（CRATUS）研究：一项I/II期随机、双盲、安慰剂对照试验，旨在评估异体人骨髓间充质干细胞输注对衰老虚弱患者的安全性和潜在疗效。
Oncotarget. 2016 Mar 15;7(11):11899-912. doi: 10.18632/oncotarget.7727.
8
Association Between Circulating Osteogenic Progenitor Cells and Disability and Frailty in Older Persons: The Nepean Osteoporosis and Frailty Study.循环成骨祖细胞与老年人残疾和衰弱的关系：尼平骨质疏松和衰弱研究。
J Gerontol A Biol Sci Med Sci. 2016 Sep;71(9):1124-30. doi: 10.1093/gerona/glv190. Epub 2015 Nov 2.
9
Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.在博来霉素诱导的慢性小鼠肺纤维化模型中，年轻而非年老的脂肪间充质干细胞的治疗益处。
Transl Res. 2015 Dec;166(6):554-67. doi: 10.1016/j.trsl.2015.09.004. Epub 2015 Sep 18.
10
Geroscience: linking aging to chronic disease.衰老学：将衰老与慢性疾病联系起来。
Cell. 2014 Nov 6;159(4):709-13. doi: 10.1016/j.cell.2014.10.039.
Zotero 插件